NFSG
EPIX

Newbridge Financial Services Group’s ESSA Pharma EPIX Stock Holding History

Newbridge Financial Services Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31
Closed -$96 – 1215
2023
Q3 		$96 Hold
31
– – ﹤0.01% 1249
2023
Q2 		$84 Hold
31
– – ﹤0.01% 1306
2023
Q1 		$92 Hold
31
– – ﹤0.01% 1364
2022
Q4 		$78 Hold
31
– – ﹤0.01% 1402
2022
Q3 		$0 Hold
31
– – ﹤0.01% 1408
2022
Q2 		$0 Hold
31
– – ﹤0.01% 1398
2022
Q1 		$0 Hold
31
– – ﹤0.01% 1468
2021
Q4 		$0 Hold
31
– – ﹤0.01% 1448
2021
Q3 		$1K Hold
31
– – ﹤0.01% 1248
2021
Q2 		$1K Hold
31
– – ﹤0.01% 1347
2021
Q1 		$1K Buy
+31
New +$721 ﹤0.01% 1261

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Newbridge Financial Services Group's EPIX Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of ESSA Pharma (EPIX) in Q4 2023, closing a stake of 31 shares — an estimated $96 sold.

Newbridge Financial Services Group first reported a position in EPIX in Q1 2021 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 31 funds tracked by Wall St. Rank hold EPIX as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining ESSA Pharma position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 31 ESSA Pharma shares in Q4 2023, an estimated $96.
  • Newbridge Financial Services Group first reported a position in ESSA Pharma in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's ESSA Pharma position peaked at $1K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.